Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Clinical trial NCT05093231 · RECRUITING
Trial details
- NCT number
- NCT05093231
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-26
- Primary completion
- 2027-07-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.